By Marie Rosenthal, MS
Although not unanimous, the Advisory Committee on Immunization Practices (ACIP) voted to restart use of the Johnson & Johnson COVID-19 vaccine without any changes in its original recommendation.
By the end of the second meeting to discuss a serious safety signal after the CDC and FDA instituted a pause in the use of this vaccine, the ACIP left two choices on the table:
- The Janssen COVID-19 vaccine is recommended for persons ages 18 years and older in the U.S.